These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 17088649)

  • 21. Hematopoietic stem cell transplantation for primary immunodeficiency disease.
    Dvorak CC; Cowan MJ
    Bone Marrow Transplant; 2008 Jan; 41(2):119-26. PubMed ID: 17968328
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New insights into cord blood stem cell transplantation.
    Tse W; Bunting KD; Laughlin MJ
    Curr Opin Hematol; 2008 Jul; 15(4):279-84. PubMed ID: 18536563
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Saving the red baby: successful allogeneic cord blood transplantation in Omenn syndrome.
    Schönberger S; Ott H; Gudowius S; Wüller S; Baron JM; Merk HF; Lassay L; Megahed M; Feyen O; Laws HJ; Dilloo D; Borkhardt A; Niehues T
    Clin Immunol; 2009 Mar; 130(3):259-63. PubMed ID: 19064334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene therapy for primary immunodeficiencies.
    Thrasher AJ
    Immunol Allergy Clin North Am; 2008 May; 28(2):457-71, xi. PubMed ID: 18424342
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Umbilical cord blood transplantation for non-malignant diseases.
    Prasad VK; Kurtzberg J
    Bone Marrow Transplant; 2009 Nov; 44(10):643-51. PubMed ID: 19802020
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unrelated donor and HLA-identical sibling haematopoietic stem cell transplantation cure chronic granulomatous disease with good long-term outcome and growth.
    Soncini E; Slatter MA; Jones LB; Hughes S; Hodges S; Flood TJ; Barge D; Spickett GP; Jackson GH; Collin MP; Abinun M; Cant AJ; Gennery AR
    Br J Haematol; 2009 Apr; 145(1):73-83. PubMed ID: 19222467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Update on the treatment of primary immunodeficiencies.
    García JM; Español T; Gurbindo MD; Casas C C
    Allergol Immunopathol (Madr); 2007; 35(5):184-92. PubMed ID: 17923072
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary immunodeficiencies.
    Cooper MA; Pommering TL; Korányi K
    Am Fam Physician; 2003 Nov; 68(10):2001-8. PubMed ID: 14655810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Allogeneic stem cell transplantation from related and unrelated donors for aplastic anaemia in adults--a single-centre experience.
    Buchholz S; Dammann E; Koenecke Ch; Stadler M; Franzke A; Blasczyk R; Bremer M; Krauter J; Hertenstein B; Ganser A; Eder M
    Ann Hematol; 2008 Jul; 87(7):551-6. PubMed ID: 18386010
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Allogeneic hematopoietic stem cell transplant using mismatched/haploidentical donors.
    Koh LP; Rizzieri DA; Chao NJ
    Biol Blood Marrow Transplant; 2007 Nov; 13(11):1249-67. PubMed ID: 17950913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Allogeneic marrow stem-cell transplantation from human leukocyte antigen-identical siblings versus human leukocyte antigen-allelic-matched unrelated donors (10/10) in patients with standard-risk hematologic malignancy: a prospective study from the French Society of Bone Marrow Transplantation and Cell Therapy.
    Yakoub-Agha I; Mesnil F; Kuentz M; Boiron JM; Ifrah N; Milpied N; Chehata S; Esperou H; Vernant JP; Michallet M; Buzyn A; Gratecos N; Cahn JY; Bourhis JH; Chir Z; Raffoux C; Socié G; Golmard JL; Jouet JP;
    J Clin Oncol; 2006 Dec; 24(36):5695-702. PubMed ID: 17116940
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcomes of unrelated umbilical cord blood transplantation for X-linked adrenoleukodystrophy.
    Beam D; Poe MD; Provenzale JM; Szabolcs P; Martin PL; Prasad V; Parikh S; Driscoll T; Mukundan S; Kurtzberg J; Escolar ML
    Biol Blood Marrow Transplant; 2007 Jun; 13(6):665-74. PubMed ID: 17531776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Costs of hematopoietic cell transplantation: comparison of umbilical cord blood and matched related donor transplantation and the impact of posttransplant complications.
    Majhail NS; Mothukuri JM; Brunstein CG; Weisdorf DJ
    Biol Blood Marrow Transplant; 2009 May; 15(5):564-73. PubMed ID: 19361748
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of postgrafting immunosuppressive regimens on nonrelapse mortality and survival after nonmyeloablative allogeneic hematopoietic stem cell transplant using the fludarabine and low-dose total-body irradiation 200-cGy.
    Koh LP; Chen CS; Tai BC; Hwang WY; Tan LK; Ng HY; Linn YC; Koh MB; Goh YT; Tan B; Lim S; Lee YM; Tan KW; Liu TC; Ng HJ; Loh YS; Mow BM; Tan DC; Tan PH
    Biol Blood Marrow Transplant; 2007 Jul; 13(7):790-805. PubMed ID: 17580257
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Matched-related donor transplantation for sickle cell disease: report from the Center for International Blood and Transplant Research.
    Panepinto JA; Walters MC; Carreras J; Marsh J; Bredeson CN; Gale RP; Hale GA; Horan J; Hows JM; Klein JP; Pasquini R; Roberts I; Sullivan K; Eapen M; Ferster A;
    Br J Haematol; 2007 Jun; 137(5):479-85. PubMed ID: 17459050
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patients with early relapse of primary hemophagocytic syndromes or with persistent CNS involvement may benefit from immediate hematopoietic stem cell transplantation.
    Sparber-Sauer M; Hönig M; Schulz AS; zur Stadt U; Schütz C; Debatin KM; Friedrich W
    Bone Marrow Transplant; 2009 Sep; 44(6):333-8. PubMed ID: 19252534
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduced-intensity conditioning regimens before unrelated cord blood transplantation in adults with acute leukaemia and other haematological malignancies.
    Rocha V; Mohty M; Gluckman E; Rio B; ; ;
    Curr Opin Oncol; 2009 Jun; 21 Suppl 1():S31-4. PubMed ID: 19561411
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Allogeneic hematopoietic stem cell transplantation in myelofibrosis: the 20-year experience of the Gruppo Italiano Trapianto di Midollo Osseo (GITMO).
    Patriarca F; Bacigalupo A; Sperotto A; Isola M; Soldano F; Bruno B; van Lint MT; Iori AP; Santarone S; Porretto F; Pioltelli P; Visani G; Iacopino P; Fanin R; Bosi A;
    Haematologica; 2008 Oct; 93(10):1514-22. PubMed ID: 18728030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term follow-up of peripheral blood stem cell transplantation from mismatched related and unrelated donors.
    Blau IW; Schmidt-Hieber M; Basara N; Hopfenmüller W; Bischoff M; Günzelmann S; Kirsten D; Schmetzer B; Roemer E; Kiehl MG; Thiel E; Fauser AA
    Clin Transplant; 2007; 21(1):110-6. PubMed ID: 17302599
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Partially matched, nonmyeloablative allogeneic transplantation: clinical outcomes and immune reconstitution.
    Rizzieri DA; Koh LP; Long GD; Gasparetto C; Sullivan KM; Horwitz M; Chute J; Smith C; Gong JZ; Lagoo A; Niedzwiecki D; Dowell JM; Waters-Pick B; Liu C; Marshall D; Vredenburgh JJ; Gockerman J; Decastro C; Moore J; Chao NJ
    J Clin Oncol; 2007 Feb; 25(6):690-7. PubMed ID: 17228020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.